10-Q

U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One) 

x  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended February 28, 2015

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT

For the transition period from ________ to ___________

Commission File No. 333136247 

Domark International, Inc.

(Name of small business issuer as specified in its charter)

Nevada	20-4647578
(State of Incorporation)	(IRS Employer Identification No.)

34 King Street, East Suite 1102 Toronto,
Ontario M5C1E9 

321-250-4996 

(Issuer's telephone number)

Securities registered under Section 12(b) of the Exchange Act:

None

Securities registered under Section 12(g) of the Exchange Act:

Common Stock, $0.001 par value per share 

(Title of Class)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation ST (ss.232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a nonaccelerated filer or a smaller reporting company.

Large accelerated filer	¨	Accelerated Filer	¨
Nonaccelerated filer	¨	Smaller reporting company	x

Indicate by check mark whether the registrant is a shell company (as defined in rule 12b2 of the Exchange Act) Yes ¨ No x

 As of February 28, 2015, there were 8,681,112,367 shares of Common Stock, $0.001 par value per share, issued and outstanding and there were 50,000 shares of Series A Preferred Stock, $0.001 par value per share, issued and outstanding and there are zero shares of Series B Preferred Stock, $0.001 par value per share, issued and outstanding.

DOMARK INTERNATIONAL, INC.

TABLE OF CONTENTS

		PAGE
PART I FINANCIAL INFORMATION
Item 1.
	Consolidated Balance Sheets February 28, 2015 (unaudited) and May 31, 2014	3
	Consolidated Statements of Operations three and nine months ending February 28, 2015 and February 28, 2014 (unaudited & unreviewed)		5
	Consolidated Statements of Cash Flows nine months ending February 28, 2015 and February 28, 2014 (unaudited & unreviewed)		6
	Notes to Consolidated Financial Statements (unaudited)		8
Item 2.	Management Discussion & Analysis of Financial Condition and Results of Operations		19
Item 3.	Quantitative and Qualitative Disclosures About Market Risk		20
Item 4.	Controls and Procedures		21

PART II OTHER INFORMATION

Item 1.	Legal Proceedings	22
Item 1A.	Risk Factors		22
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		22
Item 3.	Defaults Upon Senior Securities		22
Item 4.	Mine Safety Disclosure		22
Item 5.	Other information		22
Item 6.	Exhibits		23

2

DOMARK INTERNATIONAL, INC.  

CONSOLIDATED BALANCE SHEETS 

(UNAUDITED & UNREVIEWED) 

		February 28,		May 31,
		2015		2014
		(Unaudited )
ASSETS
CURRENT ASSETS
	Cash and cash equivalents	$	-	$	460
	Loan receivable from consultant		36,203		36,203
	Prepaid expenses		4,500		4,500
	TOTAL CURRENT ASSETS		40,703		41,163
INVESTMENTS			1,144,166		1,144,166
OTHER ASSETS
	Patents, net of accumulated amortization
	of $11,105 and $3,605, respectively		59,397		66,897
	Licenses, net of accumulated amortization
	of $215,478 and $60,898, respectively		94,522		249,102
	TOTAL OTHER ASSETS		153,919		315,999
TOTAL ASSETS		$	1,338,788	$	1,501,328

The accompanying notes are an integral part of these consolidated financial statements  

3

DOMARK INTERNATIONAL, INC. 

CONSOLIDATED BALANCE SHEETS

(UNAUDITED & UNREVIEWED)

LIABILITIES AND STOCKHOLDERS' (DEFICIT)

		February 28,			May 31,
		2015			2014
CURRENT LIABILITIES
	Amounts payable to Bank	$	65			-
	Note payable to bank		180,000		$	180,000
	Accounts payable and accrued expenses		61,770			56,940
	Amounts due under Licensing Agreement with Wazzamba SA		224,924			224,925
	Loans payable to consultants and stockholders		181,328			188,972
	Convertible notes payable (net of unamortized discounts
	of $41,818 and $674,886, respectively)		573,076			67,414
	Derivative liability for convertible notes payable		2,314,280			1,748,982
	TOTAL CURRENT LIABILITIES AND TOTAL LIABILITIES		3,535,443			2,467,233
STOCKHOLDERS' DEFICIT
	Preferred stock, $0.001 par value, authorized 10,000,000 shares:
	Series A convertible preferred stock - issued and outstanding
	50,000 shares as of February 28, 2015 and May 31, 2014		50			50
	Convertible preferred stock series B, $0.0001 par value,
	Authorized: 10,000,000		-			-
	Common stock, $0.001 par value, authorized 14,000,000,000 shares:
	8,681,112,367 and 801,626,781 shares issued,
	and 8,681,112,367 and 801,626,781 shares outstanding,
	as of February 28, 2015 and May 31, 2014		8,805,928			801,627
	Less: Treasury stock (124,819,802 shares) as of February 28, 2015 and May 31, 2014		(124,820	)		(124,820	)
	Common stock payable		858,000			858,000
	Additional paid in capital		36,194,642			43,529,923
	Other comprehensive income ( loss )		(126,453	)		(88,551	)
	Accumulated deficit		(47,804,002	)		(45,942,134	)
	TOTAL STOCKHOLDERS' DEFICIT		(2,196,655	)		(965,905	)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT		$	1,338,788		$	1,501,328

The accompanying notes are an integral part of these consolidated financial statements 

4

DOMARK INTERNATIONAL, INC.  

CONSOLIDATED STATEMENTS OF OPERATIONS 

(UNAUDITED & UNREVIEWED)

	For the three			For the three			For the nine			For the nine
	months			months			months			months
	ending			ending			ending			ending
	February 28,			February 28,			February 28,			February 28,
	2015			2014			2015			2014
Sales	$	-		$	-		$	-		$	-
Cost of sales	-			-			-			-
Gross profit	-			-			-			-
Operating expenses:
General and administrative		27,563			438,528			269,369			759,904
Stock-based compensation - Consultants		24,003			0			79,623			453,825
Stock-based compensation - Salaries and wages		0			0			0			257,476
Depreciation  and amortization expense		55,360			1,360			162,080			2,080
Total operating expenses		106,926			439,888			511,072			1,473,285
Loss from operations		(106,926	)		(439,888	)		(511,072	)		(1,473,285	)
Other income (expense):
Other income
Revaluation of derivative liability for convertible notes		101,879			(342,625	)		(565,302	)		(504,369	)
Currency Translation Loss		0			(18,569	)		0			(18,569	)
Interest expense		(441,262	)		(262,972	)		(785,492	)		(350,975	)
Total other income (expense)		(339,383	)		(624,166	)		(1,350,794	)		(873,913	)
Net Loss		(446,309	)		(1,064,054	)		(1,861,866	)		(2,347,198	)
Statement of Comprehensive Income:
Net Loss		(446,309	)		(1,064,054	)		(1,861,866	)		(2,347,198	)
Other Comprehensive loss
Foreign currency adjustment		(14,213	)		0			(37,902	)		0
		(14,213	)		0			(37,902	)		0
Total Comprehensive Loss	$	(460,522	)	$	(1,064,054	)	$	(1,899,768	)	$	(2,347,198	)
Net loss per common shares, basic and diluted	$	0.00		$	(0.01	)	$	0.00		$	(0.02	)
Weighted average common shares outstanding		7,743,112,656			138,202,346			6,582,724,800			96,680,371

The accompanying notes are an integral part of these consolidated financial statements

5

DOMARK INTERNATIONAL, INC. 

 CONSOLIDATED STATEMENTS OF CASH FLOWS 

(UNAUDITED & UNREVIEWED) 

	For the nine months ended
	February 28,			February 28,
	2015			2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	$	(1,861,866	)	$	(2,347,198	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		162,080			2,080
Common stock issued as compensation - consultants		79,623			-
Common stock issued as compensation		-			513,675
Non cash interest expense		785,492			336,064
Loss (gain) on derivative valuation		565,302			504,369
Currency loss
Change in operating assets and liabilities:
Prepaid expenses		-			3,591
Accounts payable and accrued expenses		(4,830	)		48,162
Accounts payable - related party		7,644			-
Net cash used in operating activities		(266,555	)		(939,257	)
CASH FLOWS FROM INVESTING ACTIVITIES
Cash paid for investments		-			(171,608	)
Cash paid for loan receivable from consultant		-			(36,203	)
Net cash used in investing activities		-			(207,811	)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from convertible notes payable		180,829			752,500
Proceeds from loans payable to consultants and stockholders		123,103			224,499
Payments made on loans payables to consultants & stockholders		-			(10,007	)
Proceeds received from notes payable		-			180,000
Net cash provided by financing activities		303,932			1,146,992
Other comprehensive income ( loss ) effect of exchange rate changes on cash		(37,902	)		-
Net decrease in cash and cash equivalents		(525	)		(20	)
CASH BALANCE -  BEGINNING OF PERIOD		460			20
CASH BALANCE ( BANK OVERDRAFT ) - END OF PERIOD	$	(65	)	$	-
Cash paid for interest	$	20,424		$	9,700

The accompanying notes are an integral part of these consolidated financial statements

6

DOMARK INTERNATIONAL, INC.

 CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED & UNREVIEWED)

	For the nine months ended
	February 28,		February 28,
	2015		2014
SUPPLEMENT SCHEDULE OF NON-CASH INVESTING
AND FINANCING ACTIVITIES:
Licensing Agreement with Wazzamba SA in exchange for amounts due
under Licensing agreement with Wazzamba SA	$	-	$	300,000
Shares issued for settlement of loans payable to consultants
and stockholders	$	65,102	$	52,500
Shares issued for settlement of convertible notes payable	$	487,998	$	475,664
Shares issued for patent acquisition	$	-	$	35,500
Shares issued for 19% equity interests in Imagic Ltd.	$	-	$	796,700
Convertible notes payable issued for equity interests in Imagic LTD	$	-	$	150,000

The accompanying notes are an integral part of these consolidated financial statements
 

7

DOMARK INTERNATIONAL, INC 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 

FOR THE NINE MONTHS ENDING FEBRUARY 28, 2015 AND FEBRUARY 28, 2014 

 (Unaudited & Unreviewed)

NOTE 1 – DESCRIPTION OF BUSINESS

DOMARK INTERNATIONAL, INC. ("DoMark" or the "Company") was incorporated under the laws of the State of Nevada on March 30, 2006. During 2008 and 2009, the Company acquired several operating businesses. On May 21, 2009, the Company entered into an acquisition agreement (the "Victory Lane Agreement") with Victory Lane Financial Elite, LLC ("Victory Lane") with respect to a real estate lifestyle business known as "Victory Lane" (the "Victory Lane Business"). Shortly thereafter, a dispute arose between the Company and the principals of Victory Lane regarding the representations of the principals of Victory Lane and the Victory Lane Business and the Victory Lane Agreement.

On March 5, 2012, the Company entered into an Asset Purchase Agreement with its then controlling shareholder, R. Thomas Kidd, for the sale of the Company’s subsidiary Armada Armada/The Golf Championships and certain assets related thereto. The Company relied upon Accounting Standards Codification (“ASC”) Topic Nos, 8602025 and 8602040 to record the sale. The fair value of the transaction was measured at the fair value of the assets less any liabilities sold.

On February 29, 2012, the Company formed a new wholly owned subsidiary, Solarwerks, Inc. in the state of Nevada, for the purposes of entering the business of marketing specialized solar consumer electronics. Solarwerks' current focus is to develop and distribute the SolaPad, a combined cover and charging system for Apple's iPad; and the SolaCase, a combined cover and charging system for all versions of Apple's iPhone. Solarwerks competes in a market that also includes 3D Systems (DDD), Dell (DELL) and Hewlett Packard (HPQ). Solarwerks, Inc. is currently in default with the Nevada Secretary of State.

On June 20, 2012, the Company formed a new whollyowned subsidiary, MuscleFoot Inc. in the state of Nevada for the purpose of distributing, marketing, and acting as sales agent for the patented foot care system of Barefoot Science. MuscleFoot Inc. is currently in default with the Nevada Secretary of State.

On July 20, 2012, the Company formed a new whollyowned subsidiary, DoMark Canada Inc. in the province of Ontario for the purpose of supporting the Company’s corporate operations based in Toronto, Ontario, Canada.

On February 28, 2013, the Company entered into a Memorandum of Understanding to purchase 44% of Zaktek Ltd. (“Zaktek”). Zaktek’s main product is the phonepad+, an Apple Inc. approved tablet device that works with smartphones, including the Apple iPhone® and Samsung Galaxy products to improve functionality including video and gaming abilities.

On April 23, 2013, the Company received notification that Zaktek was ending discussions in regards to the definitive purchase agreement with DoMark.

On June 11, 2013, the Company then purchased 100% of South Hill Ltd., an English private limited company, which owns approximately 19% of Zaktek.

NOTE 2 – GOING CONCERN

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America which contemplate continuation of the Company as a going concern. Furthermore, the Company has inadequate working capital to maintain or develop its operations, and is dependent upon funds from private investors, promissory notes from lenders, and the support of certain stockholders.

These factors raise substantial doubt about the ability of the Company to continue as a going concern. These condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty. In this regard, management is planning to raise any necessary additional funds through loans and additional sales of its common stock. There isn’t any assurance that the Company will be successful in raising additional capital to meet its operating needs.

8

NOTE 3 – BASIS OF PRESENTATION

The unaudited consolidated financial statements as of February 28, 2015 and for the nine months ended February 28, 2014 have been prepared in accordance with accounting principles generally accepted in the United States for interim consolidated financial information and with instructions to Form 10-Q. In the opinion of management, the unaudited consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the consolidated financial position as of February 15, 2015 and the results of operations and cash flows for the nine months ended February 28, 2015 and 2014. The financial data and other information disclosed in these notes to the interim consolidated financial statements related to these periods are unaudited. The results for the nine month period February 28, 2015 are not necessarily indicative of the results to be expected for any subsequent quarter of the entire year ending May 31, 2015. The consolidated balance sheet at February 28, 2015 has been derived from the unaudited consolidated financial statements at that date.

Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States have been omitted pursuant to the Securities and Exchange Commission’s rules and regulations. These unaudited consolidated financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended May 31, 2014 as included in our annual report on Form 10-K.

NOTE 4 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

RECENT ACCOUNTNG PRONOUNCEMENTS

In June 2014, The Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 201410, “Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation” (“ASU 201410”). ASU 201410 removes the financial reporting distinction between development stage entities and other reporting entities and eliminates the requirements for development stage entities to (1) present inceptiontodate information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. As permitted by ASU 201410, the Company has elected early application of this standard for the accompanying consolidated financial statements for the Quarter ended February 28, 2015 and year ended May 31, 2014. The Company has reviewed other recently issued accounting pronouncements and plans to adopt those that are applicable to it. It does not expect the adoption of these pronouncements to have a material impact on its financial position, results of operations or cash flows.

PRINCIPLES OF CONSOLIDATION

The accompanying consolidated financial statements represent the consolidated financial position and results of operations of the Company and include the accounts and results of operations of the Company and its subsidiaries. The accompanying consolidated financial statements include the parent entity of DoMark International, Inc. and its wholly owned subsidiaries, Domark Canada, Inc., Solarwerks, Inc., MuscleFoot, Inc. The Company has relied upon the guidance provided by ASC Topic No. 81010153.

Foreign Currency Translation and Transaction Gains and Losses

We record foreign currency translation adjustments and transaction gains and losses in accordance with SFAS 52, Foreign Currency Translation. For our operations that have a functional currency other than the U.S. dollar, gains and losses resulting from the translation of the functional currency into U.S. dollars for financial statement presentation are not included in determining net loss but are accumulated in the cumulative foreign currency translation adjustment account as a separate component of shareholders’ deficit. The Company and its subsidiaries also have transactions in foreign currencies other than the functional currency. We record transaction gains and losses in our consolidated statements of income related to the recurring measurement and settlement of such transactions. The translation rates as of February 28, 2015 were $1.00 US equaled $1.25 Canadian.

9

USE OF ESTIMATES

The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates.

The primary management estimates included in these condensed consolidated financial statements are the fair value of Company stock tendered in various nonmonetary transactions and the fair value of the derivative liability for convertible notes payable.

CASH AND CASH EQUIVALENTS

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At February 28, 2015 there weren’t any cash or cash equivalents. At May 31, 2014, cash and cash equivalents consisted only of cash in the bank.

LOANS RECEIVABLE CONSULTANT

The loan receivable consultants are a short term, less than one year note, due July 15, 2015 and noninterest bearing.

NET LOSS PER COMMON SHARE

Basic net loss per common share is computed by dilutive net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially dilutive securities (such as convertible notes payable, convertible preferred stock, and warrants) outstanding during the relevant period. Dilutive securities having an antidilutive effect on diluted net loss per common share are excluded from the calculation.

For the nine months ending February 28, 2015 and 2014, diluted common shares outstanding excluded the following dilutive securities as the effect of their inclusion was antidilutive:

	Common Shares Equivalent Nine Months Ended February,
	2015		2014
Convertible notes payable		307,459,536		2,163,265
Series A convertible preferred stock		50,000,000		50,000,000
Warrants		850,000		850,000
Total common shares equivalent		358,309,536		53,013,265

INTANGIBLE ASSETS

Intangible assets are carried at cost less accumulated amortization. Amortization is recorded over the estimated useful lives of the respective assets.

10

IMPAIRMENT OF LONGLIVED ASSETS

In accordance with ASC Topic No. 3601040, longlived assets, such as property, plant, and equipment, and purchased intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment annually. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.

STOCKBASED COMPENSATION

The Company accounts for share based payments in accordance with ASC Topic No. 718, Compensation Stock Compensation, which requires all sharebased payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 71810309, Measurement Objective Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For stock options, the Company uses the BlackScholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as stock volatility, interest rates, and to allow for actual exercise behavior of option holders. Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued free trading shares from the Company’s authorized common stock.

ASC Topic No. 505, "CompensationStock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to nonemployees for goods or services. Under this method, stock compensation expense includes compensation expense for all stockbased compensation awards granted on or after January 1, 2006, based on the grantdate fair value estimated in accordance with the provisions of ASC 505.

RESEARCH AND DEVELOPMENT

All research and development expenditures are expensed as incurred.

REVENUE RECOGNITION

The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery and acceptance has occurred or service has been rendered, the price is fixed or determinable, and collection of the resulting receivable is reasonably assured.

11

NOTE 5 – INVESTMENTS

Investments consist of:

	February 28, 2015		May 31, 2014
Imagic Ltd. 40% equity interest	$	1,094,166	$	1,094,166
Barefoot Science Products & Services Inc. 15% equity interest		50,000		50,000
Total	$	1,144,166	$	1,144,166

The cost of the 40% equity interest in Imagic Ltd. at November 30, 2014 consists of:

July 22, 2013 issuance of 7,500,000 shares of DoMark common stock to Imagic Ltd.	$	697,500
December 3, 2013 issuance of 8,000,000 shares of DoMark common stock to Meadow Grove Ltd. in exchange for 9% equity interest in Imagic Ltd.			96,005
Cash payments to or for the benefit of Imagic Ltd.			150,661
Payments from Foremark Holdings to Imagic Ltd. in exchange for DoMark notes payable to Foremark Holdings			150,000
Total	$		1,094,166

Imagic is a privately owned company registered in Gibraltar which owns proprietary product designs for its Digilink and Game Control products. Imagic shares are not quoted or traded on any securities exchange or in any recognized overthe counter market. Imagic is accounted for on the equity method of accounting. The Company consolidates entities that we control. The Company accounts for investments in joint ventures using the equity method of accounting when we exercise significant influence over the venture. If the Company does not exercise significant influence, we account for the investment using the cost method of accounting. Imagic did not have any revenues or expenses for the period ended February 28, 2015.

NOTE 6 – LICENSING AGREEMENT WITH WAZZAMBA SA

During the three months ended February 28, 2014, the Company executed a Licensing Agreement with Wazzamba SA (the “Licensor”). The agreement provides the Company an exclusive license to use certain technology (which permits thirdparty subscribers to integrate a fully equipped online shop into their websites) in Canada and the United States for an initial term ending July 31, 2015. The agreement provides for the Company to pay the Licensor “Flat Fee” compensation of $ 300,000 in 3 installments of $100,000 each (first installment payable within 5 days of the signing of the agreement, second installment payable on July 1, 2014, and third installment payable on February 1, 2015) plus “Revenue Share” compensation equal to 50% of Net Commissions generated by the Company payable monthly. In the event that the Company does not generate $500,000 in Net Commissions by January 31, 2015, the Licensor has the right to cancel the agreement with one month notice (in which case the third $100,000 installment will no longer be due). With respect to an Extended License Term after July 31, 2015, the agreement provides the Company a right of first refusal to match any offer received by the Licensor from a third party.

At February 28, 2015, the Company has a recorded intangible asset for “Licensing Agreement with Wazzamba SA” in the amount of $300,000, and included the liability under the Licenses net of accumulated amortization. Commencing March 1, 2014, the Company will amortize the $300,000 intangible asset on a straight line basis over the remaining 17 months of the Initial Term ending July 31, 2015 (approximately $17,647 per month).

On March 27, 2014, the Company paid $75,000 of the first $300,000 “Flat Fee” installment due the Licensor under the agreement. The other $225,000 due is presently past due.

12

Licenses, net of accumulated amortization are as follows:

	February 28,			February 28,
	2015			2014
Wazzamba S. A.	$	300,000		$	300,000
Bio harmonics		10,000			10,000
Subtotal		310,000			310,000
Accumulated amortization		(215,478	)		(60,698	)
Totals	$	94,522		$	249,302

NOTE 7 – NOTE PAYABLE TO BANK

In December 2013, the Company entered into a Loan Agreement with a bank located in Maryland. The related Promissory Note in the amount of $180,000 bears interest at a rate at 10% payable monthly, and is due in full on December 31, 2014, and is secured by a 25,000,000 shares of Domark International, Inc (Common Stock Reserve as defined in the Loan Agreement), a Guaranty of Payment from the Company’s chief financial officer and his wife, and certain real property owned by the Company’s chief financial officer and his wife. The loan has been modified and the lender has extended a six month extension for the loan repayment, with a July 1, 2015 balloon due date.

NOTE 8 – LOANS PAYALE TO CONSULTANTS AND STOCKHOLDERS
  
Loans payable to consultants and stockholders consist of;                  

	February 28,		May 31,
	2015		2014
Consultant and stockholder	$	80,796	$	90,402
President of Domark		45,850		47,500
Non-exec Chairman of Domark		-		11,875
Chairman of Barefor Science and affilliate		21,500		21,500
Consultant		16,097		16,097
Consultant		17,085		1,598
Totals	$	181,328	$	188,972

These loans are informal and do not provide for interest or a stated maturity date

13

NOTE 9 – CONVERTIBLE NOTES PAYABLE   

At February 28, 2015 the convertible notes payable consisted of;                  

Date of		Interest			Maturity	Principal			Unamortized		Net
Note	Noteholder	Rate			Date	Amount			Discount		Note
12/19/13	JMJ Financial Inc		10	%	12/19/14	$	24,842	(i)	$	0	$	24,842
3/7/14	JSJ Investments, Inc.		12	%	10/7/14		12,130	(g)		0		12,130
3/28/14	Redwood Fund III		10	%	9/28/14		35,122	(f)		0		35,122
3/18/14	Redwood Managament, LLC.		10	%	9/28/14		50,000	(g)		0		50,000
4/14/14	WHC Capital, Inc		12	%	10/14/14		38,200	(i)		0		38,200
4/11/14	Tonaquint, Inc		12	%	10/11/14		40,559	(g)		0		40,559
4/24/14	JSJ Investments, Inc.		12	%	10/24/14		50,000	(g)		0		50,000
5/12/14	Iconic Holdings, LLC		10	%	11/12/14		46,645	(g)		0		46,645
5/16/14	KBM Worldwide, Inc		8	%	11/14/14		9,410	(l)		0		9,410
6/3/14	Adar Bays, Inc		8	%	12/12/14		48,654	(g)		0		48,654
6/23/14	JMJ Financial Inc		10	%	12/23/14		50,000	(i)		0		50,000
7/3/14	LG Capital, Inc		8	%	1/3/15		36,750	(a)		0		36,750
7/22/14	Redwood Fund III		10	%	1/22/15		100,082	(g)		0		100,082
8/14/14	KBM Worldwide, Inc		8	%	2/14/15		27,500	(l)		0		27,500
10/8/14	LG Capital, Inc		8	%	4/8/15		3,000	(a)		52		2,948
12/2/14	Tonaquint, Inc		12	%	6/2/15		10,000	(g)		9,900		100
12/5/14	LG Capital, Inc.		8	%	6/5/15		9,500	(a)		9402		98
1/7/15	LG Capital Inc		8	%	7/7/15		22,500	(a)		22,464		36
	Totals					$	614,894		$	41,818	$	573,076

Legend

(a)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.081 or 50% of the average of the three lowest closing prices during the 10 trading days prior to the notice of conversion.
(b)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.085 or 60% of the lowest closing price during the 25 trading days prior to the notice of conversion.
(c)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.08 or 50% of the lowest closing price during the 10 trading days prior to the notice of conversion.
(d)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.0725 or 34% of the lowest closing price during the 20 trading days prior to the notice of conversion.
(e)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 55% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.
(f)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.00929 or 50% of the average of the three lowest trading prices during the 10 trading days prior to the notice of conversion.
(g)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 25% of the lowest trading price during the 20 trading days prior to the notice of conversion.
(h)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 58% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.
(i)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest closing price during the 25 trading days prior to the notice of conversion.
(j)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest closing price during the 20 trading days prior to the notice of conversion.
(k)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 58% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.
(l)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 49% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.

14

NOTE 10 – STOCKHOLDERS’ EQUITY

Series A Convertible Preferred Stock

Each share of Series A Convertible Preferred Stock has 1,000 voting rights and is convertible into 1,000 shares of common stock.

Common Stock Issuances

On December 1, 2014, the Company issued 233,356,500 shares of common stock for LG Capital, Inc. in satisfaction of $4,667 of principal amount of convertible notes payable.

On December 3, 2014, the Company issued 164,350,200 shares of common stock for Redwood Fund III, Inc.in satisfaction of $ 3,287 of principal amount of convertible notes payable.

On December 5, 2014, the Company issued 228,000,000 shares of common stock for KBM Worldwide, Inc. in satisfaction of $11,400 of principal amount of convertible notes payable.

On December 10, 2014, the Company issued 128,428,577 shares of common stock for Iconic Holdings, LLC in satisfaction of $ 3,148 of principal amount of convertible notes payable

On December 10, 2014, the Company issued 200,000,000 shares of common stock for WHC Capital, Inc. in satisfaction of $4,800 of principal amount of convertible notes payable.

On December 10, 2014, the Company issued 157,500,000 shares of common stock for Tonaquint, Inc. in satisfaction of $3,937 of principal amount of convertible notes payable.

On December 16,, 2014, the Company issued 307,937,698 shares of common stock for JSJ Investments, Inc. in satisfaction of $7,698 of principal amount of convertible notes payable.

On December 22, 2014, the Company issued 318,000,000 shares of common stock for JMJ Financial, Inc. in satisfaction of $19,080 of principal amount of convertible notes payable.

On December 30, 2014, the Company issued 153,846,000 shares of common stock for Adars Bay, Inc. in satisfaction of $3,846 of principal amount of convertible notes payable.

On December 31, 2014, the Company issued 181,200,000 shares of common stock for KBM Worldwide, Inc. in satisfaction of $9,060 of principal amount of convertible notes payable.

On December 31, 2014, the Company issued 256,044,000 shares of common stock for LG Capital, Inc.in satisfaction of $5,121 of principal amount of convertible notes payable.

On December 31, 2014, the Company issued 46,800,000 shares of common stock for KBM Worldwide, Inc. in satisfaction of $2,340 of principal amount of convertible notes payable.

On December 31, 2014, the Company issued 181,200,000 shares of common stock to KBM Worldwide, Inc. in satisfaction of $9,060 of principal amount of convertible notes payable.

On December 31, 2014, the Company issued 256,044,000 shares of common stock to LG Capital, Inc., Inc. in satisfaction of $5,121 principal amount of convertible notes payable.

On January 12, 2015, the Company issued 160,000,000 shares of common stock to Tonaquint, Inc.in satisfaction of $4,000 principal amount of convertible notes payable.

On February 17, 2015, the Company issued 280,600,000 shares of common stock to KBM Worldwide, Inc. in satisfaction of $ 14,030 principal amount of convertible notes payable.

15

Warrants to Purchase Common Stock

A summary of warrant activity for the nine months ending February 28, 2015 and for the year ended May 31, 2014 are as follows:

	Weighted Average Number of Warrants		Exercise Price
Outstanding at May 31, 2013	$	-	$	-
Granted		850,000		0.42
Exercised		-		-
Cancelled		-		-
Outstanding at May 31, 2014		850,000		0.42
Granted		-		-
Exercised		-		-
Cancelled		-		-
Outstanding at February 28, 2015	$	850,000	$	0.42

Warrants outstanding at February 28, 2015 consist of:

Date Granted	Number Outstanding		Exercise price		Expiration Date
May 25, 2012		100,000	$	1.00	May 25, 2015
June 12, 2012		150,000	$	1.00	June 12, 2015
June 26, 2012		100,000	$	1.00	June 26, 2015
January 1, 2012		500,000	$	0.01	January 1, 2015
Totals		850,000

NOTE 11 – FAIR VALUE MEASUREMENTS AND DERIVATIVE LIABILIITY

The Company evaluates all of it financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then revalued at each reporting ate, with changes in the fair value reported as charges or credits to income. For optionbased derivative financial instruments, the Companyuses the BlackScholes optionpricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is reassessed at the end of each reporting period derivative instrument liabilities are classified in the balance sheet as current or noncurrent based on whether or not netcash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

16

During the period ended February 28, 2015 the Company entered into several convertible note agreements. The conversion option and the outstanding common stock warrants on that date which were tainted by the convertible note were classified as derivative liabilities at their fair value on the date of issuance.

Under ASC 815 the conversion options embedded in the notes payable described in Note 9 require liability classification because they do not contain an explicit limit to the number of shares that could be issued upon settlement.

As defined in FASB ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilized the market data of similar entities in its industry or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. FASB ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).

The three levels of the fair value hierarchy are as follows:

Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchangetraded derivatives, marketable securities and listed equities.

Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date.

Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

Derivative liability – the Company’s derivative liability is classified within Level 3 of the fair value hierarchy.

The Company uses the Black Scholes Option Pricing Model to value its option based derivatives predicated upon the following assumptions: dividend yield of 0%, volatility of stock price =100%, risk free interest rate varying from 8 to 12 % and an expected term equal to the remaining conversion period of the note.

The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value as of February 28, 2015.

Recurring Fair Value Measurements	Level 1		Level 2		Level 3		Total
LIABILITIES:
Derivative liability February 28, 2015		-		-		2,314,280		2,314,280
Derivative liability May 31, 2014		-		-		1,748,982		1,748,982

17

NOTE 12 – COMMITMENTS AND CONTINGENCIES

License Agreements

On February 29, 2012, the Company entered into a Memorandum of Agreement with Xiamen Taiyang Neng Gongsi and Michael Franklin. For and in consideration of the payment of an initial license fee of $10,000, and for the future payment of royalties of $5.00 per SolaPad unit sold, Xiamen granted an exclusive worldwide license and joint patent rights to the Company for a solar charging case for IPAD, including IPAD 3. The license under the Agreement expires on December 31, 2018.

On April 19, 2013, our subsidiary DoMark Canada Inc. executed an agreement with Bioharmonics Technologies Cop. (“Bioharmoniecs”). The agreement provided for the acquisition of certain inventions and related patents and patent applications in exchange for 500,000 shares of DoMark common stock (which was delivered April 19, 2013) and $30,000 cash payable no later than October 17, 2013 (which was satisfied through the delivery of an additional 500,000 shares of DoMark common stock to Bioharmonics on August 15, 2013). The agreement also provides for a royalty obligation payable quarterly to Bioharmonics equal to 10% of the wholesale price for each unit using infrared and solar charging.

In January 2014, the Company executed a Licensing Agreement with Wazzamba SA. See Note 6.

Employment Agreements

On May 25, 2012, the Company entered into an employment agreement with its President, R. Brentwood Strasler, for an indefinite period or until terminated. Mr. Strasler is entitled to an annual salary of $150,000 USD and 100,000 stock purchase warrants exercisable to purchase shares of common stock of the Company at $1.00 per share. The warrants are exercisable for a three year period and can be vested quarterly on a pro rata basis over twelve months from the date of issue. Additionally, Mr. Strasler is to be enrolled in a long term Executive Option Plan and is entitled to term life insurance in the face amount of $2,500,000, payable to the beneficiary designated by Mr. Strasler.

On June 15, 2012, the Company entered into an employment agreement with its Chief Executive Officer Andrew Ritchie, for an indefinite period or until terminated. Mr. Ritchie is entitled to an annual salary of $240,000 USD and 150,000 stock purchase warrants exercisable to purchase shares of common stock of the Company at $1.00 per share. The warrants are exercisable for a three year period and can be vested quarterly on a pro rata basis over twelve months from the date of issue. Additionally, Mr. Ritchie is to be enrolled in a long term Executive Option Plan and is entitled to term life insurance in the face amount of $2,500,000, payable to the beneficiary designated by Mr. Richie.

Lease Agreement

On August 1, 2013, the Company entered into an office lease in Toronto, Ontario, Canada for a five year period. At February 28, 2015, the future lease commitments on this lease for the years ended May 31, are as follows, and are in U.S. dollars:

2015	$	11,264
2016		47,616
2017		47,616
2018		47,616
Thereafter		7,936
Total	$	162,047

NOTE 13 – SUBSEQUENT EVENT

In January 2015, the Company entered into a joint venture agreement with Mobil Lads, Corp, to acquire 60% of Simbadeals North American licensing rights, for $700,000 value of Mobile Lads Corp common stock and $225,000 in cash. The cash will be used by Domark to pay off the existing licensing responsibilities to Wazzamba ( the program developer of Simbadeals). Mobil Lads Corp will manage the future of Simbadeals and will be fully responsible for all future funding requirements of the operation. Domark will retain a 25% interest in the Joint Venture. As of February 28, 2015 the Joint Venture payment to Domark International, Inc. from Mobil Lads, Inc. has not been made.

18

ITEM 2 MANAGEMENT DISCUSSION AND ANALYSIS OF THE CONSOLIDATED FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following is management's discussion and analysis of certain significant factors that have affected our condensed consolidated financial position and operating results during the periods included in the accompanying condensed consolidated financial statements, as well as information relating to the current plans of our management. This report includes forwardlooking statements. Generally, the words "believes", "anticipates", "may", "will", "should", "expect", "intend", "estimate", "continue", and similar expressions or the negative thereof or comparable terminology are intended to identify forwardlooking statements.

Such statements are subject to certain risks and uncertainties, including the matters set forth in this report or other reports or documents we file with the Securities and Exchange Commission from time to time, which could cause actual results or outcomes to differ materially from those projected. Undue reliance should not be placed on these forwardlooking statements, which speak only as of the date hereof. We undertake no obligation to update these forwardlooking statements.

The following discussion and analysis should be read in conjunction with our consolidated financial statements and the related notes thereto and other financial information contained elsewhere in this Form 10-Q.

RECENT DEVELOPMENTS

The main operations of the Company have been to search, negotiate and acquire ownership interests in companies with products at an advanced stage of their development or products already in production.

In December 2013, the Company increased its equity interest in Imagic Ltd. to 40%. Imagic is a company registered in Gibraltar which owns proprietary product designs for its Digilink and Game Control products.

In January 2014, the Company acquired United States and Canada marketing rights to certain online shop technology pursuant to a Licensing Agreement with Wazzamba SA.

On February 24, 2014, the Company increased the number of authorized shares of common stock to 900,000,000 shares.

On August 11, 2014 the Company increased the number of authorized shares of common stock to 7,500,000,000.

On December 15, 2014, R. Brent Strasler ( non Exec. Chariman) tendered his resignation to the Company, mutually agreed upon by the President/CEO.

On August 11, 2014 the Company increased the number of authorized shares of common stock to 7,500,000,000.

On December 9, 2014 the Company increased the number of authorized shares of common stock to 14,000,000,000.

In January 2015, the Company entered into a joint venture agreement with Mobil Lads, Corp, to acquire 75% of Simbadeals North American licensing rights, for $700,000 value of Mobile Lads Corp common stock and $225,000 in cash. The cash will be used by Domark to pay off the existing licensing responsibilities to Wazzamba ( the program developer of Simbadeals). Mobil Lads Corp will manage the future of Simbadeals and will be fully responsible for all future funding of the operation. Domark will retain the 25% interest in the Joint Venture.

19

LIQUIDITY AND CAPITAL RESOURCES

Our operating requirements have been funded primarily through financing facilities, sales of our common stock, and loans from shareholders and 3rd party financiers. Currently, the Company's cash flows do not adequately support the operating expenses of the Company. We received $0 in the nine months ended February 28, 2015 from the sale of our common stock. The Company will continue to require financing from loans and notes payable until such time as our business has generated income sufficient to carry our operating costs.

Cash used by operating activities for the nine month period ended February 28, 2015 was $266,555 compared to $939,257 for the same period in 2014. Stockbased compensation for the nine month period ended February 28, 2015 was $79,623 as compared to $711,301 for the nine month period ended February 28, 2014.

Cash used in investing activities was $0 for the nine month period ended February 28, 2015 compared to $207,811 for the nine month period ended February 28, 2014. Cash provided by financing activities was $303,932 for the nine month period ended February 28, 2015 versus $1,146,992 for the nine month period ended February 28, 2014. Financing activities consisted of cash received from related parties, promissory convertible notes payable, and notes payable.

OTHER CONSIDERATIONS

There are numerous factors that affect the Company's business and the results of its consolidated operations. Sources of these factors include general economic and business conditions, federal and state regulation of business activities, the level of demand for services, the level and intensity of competition, and our ability to continue to improve our infrastructure, including personnel and systems, to keep pace with our anticipated rapid growth in the development of our business.

RESULTS OF CONDENSED CONSOLIDATED OPERATIONS

NINE MONTHS ENDED FEBRUARY 28, 2015 VS FEBRUARY 28, 2014

The Company did not have any revenues for the nine months ending February 28, 2015 and February 28, 2014

Total general and administrative expenses for the nine months ending February 28, 2015 were $269,369 compared to $759,904 for the same nine month period in 2014. The decrease is primarily due to the lesser stock based compensation amounts for the period ending February 28, 2015.

The net loss for the nine months ending February 28, 2015 amounted to $1,899,763 for a net loss per share of $0.00, vs. a net loss of $2,347,198 and a net loss per share of $0.02 for the same nine month period ending in 2014. The decrease was primarily due to reduced stock based compensation and general and administrative costs.

ITEM 3 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable to smaller reporting companies.

20

ITEM 4 CONTROLS AND PROCEDURES

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

Our management team, under the supervision and with the participation of our principal executive officer and our principal financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as such term is defined under Rule 13a15(e) promulgated under the Securities Exchange Act of 1934, as amended ("Exchange Act"), as of the last day of the fiscal period covered by this report, November 30, 2013. The term disclosure controls and procedures means our controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to management, including our principal executive and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were not effective as of November 30, 2014. Management is working on hiring other responsibilities to add some internal control procedures.

Our principal executive officer and our principal financial officer are responsible for establishing and maintaining adequate internal controls over financial reporting, as such term is defined in Exchange Act Rules 13a15(f). Management is required to base its assessment of the effectiveness of our internal control over financial reporting on a suitable, recognized control framework, such as the framework developed by the Committee of Sponsoring Organizations ("COSO"). The COSO framework, published in INTERNAL CONTROLINTEGRATED FRAMEWORK, is known as the COSO Report. Our principal executive officer and our principal financial officer have chosen the COSO framework on which to base its assessment. Based on this evaluation, our management concluded that our internal control over financial reporting was not effective as of February 28, 2015.

There weren't any changes in our internal control over financial reporting that occurred during the period ended February 28, 2015 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting. Controls are being put in place for daily operations which will allow for controlled cash management and oversite.

It should be noted that any system of controls, however well designed and operated, can provide only reasonable and not absolute assurance that the objectives of the system are met. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of certain events. Because of these and other inherent limitations of control systems, there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.

Management is aware that there is a lack of segregation of duties at the Company due to the small number of employees dealing with general administrative and financial matters. However, at this time management has decided that considering the abilities of the employees now involved and the control procedures in place, the risks associated with such lack of segregation are low and the potential benefits of adding employees to clearly segregate duties do not justify the substantial expenses associated with such increases. Management will periodically reevaluate this situation.

21

PART II OTHER INFORMATION

ITEM 1 LEGAL PROCEEDINGS

On May 21, 2009, the Company entered into an Agreement for the Exchange of Common Stock (the "Victory Lane Agreement") with Victory Lane Financial Elite, LLC ("Victory Lane") with respect to a real estate lifestyle business known as Victory Lane (the "Victory Lane Business") pursuant to which the Company intended to purchase the Victory Lane Business. Shortly thereafter, a dispute arose between the Company and Victory Lane regarding alleged misrepresentations made by Victory Lane in connection with the Victory Lane Agreement.

In August, 2009, Victory Lane Financial Elite, LLC, Legacy Development, LLC and Patrick Costello filed suit in the Superior Court of Tattnall County, Georgia (Civ. No. 2009V381JW) against the Company, R. Thomas Kidd and various officers and directors of the Company, alleging that the Company was in breach of the Victory Lane Agreement and that the Company and certain of the individual defendants had committed various torts against the plaintiffs and that certain of the individual defendants had violated various fiduciary and other duties owed to the plaintiffs in connection with the Victory Lane Agreement and the handling of the Victory Lane Business (the "VLFE Case"). The plaintiffs sought a declaratory judgment to the effect that the Victory Lane Agreement had not been executed, as well as money damages from the Company and the individual defendants. The Company and Mr. Kidd have answered the Complaint, denying any liability for the plaintiff's claims and have asserted various counterclaims including fraud and other torts. In July 2010 the court dismissed all of the individual defendants, other than R. Thomas Kidd, in response to a motion to dismiss for lack of jurisdiction. The case has since been stayed.

In December, 2009, AHIFO21, LLC filed a lawsuit in the Superior Court of Tattnall County, Georgia (Civ. No. 2009V672JS) against Victory Lane, LLC, Patrick J. Costello and Stephen Brown (the "Victory Lane Defendants") alleging that the Victory Lane Defendants owe the plaintiff more than $7,740,000 in respect of one or more loans made by the plaintiff to certain Victory Lane Defendants in connection with the Victory Lane Business (the "AHIFO Case"). In February 2010, the Victory Lane Defendants filed a Third Party Complaint against the Company and R. Thomas Kidd, claiming that the Company and Mr. Kidd should be liable for any amounts the Victory Lane Defendants are required to pay to the plaintiff in this case. The Company and Mr. Kidd have answered the Complaint, denying any liability for the plaintiff's claims and Mr. Kidd has asserted various counterclaims including fraud and other torts. The Company and Mr. Kidd filed a motion to dismiss the Third Party Complaint, but the entire case was subsequently stayed.

Because each of the VLFE Case and the AHIFO Case have been stayed and because discovery in those cases is not complete, the Company has determined that the probability of any loss is remote and that the amount of any damages, if any were determined adverse to the Company, would not be reasonably estimable. The Company believes that it has meritorious claims against the opposing parties with respect to the Victory Lane Agreement and that the claims asserted against it are not meritorious. The Company intends to defend itself vigorously.

ITEM 1A RISK FACTORS

Not required.

ITEM 2 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3 DEFAULTS UPON SENIOR SECURITIES

There were no defaults upon senior securities during the interim period ended November 30, 2014.

ITEM 4 MINE SAFETY DISCLOSURE

None.

ITEM 5 OTHER INFORMATION

None.

22

ITEM 6 EXHIBITS

Exhibit No.	Document Description
31.1	Certification of CEO Pursuant to 18 U.S.C. Section 1350, Pursuant to Section 302 of the SarbanesOxley Act of 2002.
31.2	Certification of CFO Pursuant to 18 U.S.C. Section 1350, Pursuant to Section 302 of the SarbanesOxley Act of 2002.
32.1*	Certification of CEO Pursuant to 18 U.S.C. Section 1350, Pursuant to Section 906 of the SarbanesOxley act of 2002.
32.2*	Certification of CFO Pursuant to 18 U.S.C. Section 1350, Pursuant to Section 906 of the SarbanesOxley act of 2002.
101	Interactive data files pursuant to Rule 405 of Regulation ST.

______________

* This exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 of the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.

23

SIGNATURES

In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, there unto duly authorized.

	DOMARK INTERNATIONAL, INC. REGISTRANT
Date: April 20, 2015	By:	/s/ Andrew Ritchie
		Andrew Ritchie
		Chief Executive Officer/President

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the undersigned on behalf of the registrant and in the capacities indicated on the 20th day of April 2015.

By:	/s/ Thomas Crompton
	Thomas Crompton
	Chief Financial Officer

24

EX-31.1

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULES 13A-14 AND 15D-14 OF THE SECURITIES EXCHANGE ACT OF 1934

I, Andrew Ritchie, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of DoMark International, Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;
4.	The small business issuer's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the small business issuer and have:

a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.	Evaluated the effectiveness of the small business issuer's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.	Disclosed in this report any change in the small business issuer's internal control over financial reporting that occurred during the small business issuer's most recent fiscal quarter (the small business issuer's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect the small business issuer's internal control over financial reporting; and

5. The small business issuer's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the small business issuer's auditors and the audit committee of the small business issuer's board of directors (or persons performing the equivalent functions):

a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer's ability to record, process, summarize and report financial information; and
b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer's internal control over financial reporting.

April 20, 2015	By:	/s/ Andrew Ritchie
		Andrew Ritchie
		Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULES 13A-14 AND 15D-14 OF THE SECURITIES EXCHANGE ACT OF 1934

I, Thomas Crompton, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of DoMark International, Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;
4.	The small business issuer's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the small business issuer and have:

a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.	Evaluated the effectiveness of the small business issuer's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.	Disclosed in this report any change in the small business issuer's internal control over financial reporting that occurred during the small business issuer's most recent fiscal quarter (the small business issuer's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect the small business issuer's internal control over financial reporting; and

5. The small business issuer's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the small business issuer's auditors and the audit committee of the small business issuer's board of directors (or persons performing the equivalent functions):

a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer's ability to record, process, summarize and report financial information; and
b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer's internal control over financial reporting.

April 20, 2015	/s/ Thomas Crompton
	Thomas Crompton
	Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of DoMark International, Inc. (the "Company") on Form 10-Q for the period ended February28, 2015 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Andrew Ritchie, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, That to the best of my knowledge:

(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

April 20, 2015	/s/ Andrew Ritchie
	Andrew Ritchie
	Chief Executive Officer

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of DoMark International, Inc. (the "Company") on Form 10-Q for the period ended February 28, 2015 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Thomas Crompton, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, That to the best of my knowledge:

(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

April 20, 2015	/s/ Thomas Crompton
	Thomas Crompton
	Chief Financial Officer

XML

Commitments and Contingencies

9 Months Ended

Feb. 28, 2015

Notes to Financial Statements

Note 12 - Commitments and Contingencies

License Agreements

On February 29, 2012, the Company entered into a Memorandum of Agreement with Xiamen Taiyang Neng Gongsi and Michael Franklin. For and in consideration of the payment of an initial license fee of $10,000, and for the future payment of royalties of $5.00 per SolaPad unit sold, Xiamen granted an exclusive worldwide license and joint patent rights to the Company for a solar charging case for IPAD, including IPAD 3. The license under the Agreement expires on December 31, 2018.

On April 19, 2013, our subsidiary DoMark Canada Inc. executed an agreement with Bioharmonics Technologies Cop. (“Bioharmoniecs”). The agreement provided for the acquisition of certain inventions and related patents and patent applications in exchange for 500,000 shares of DoMark common stock (which was delivered April 19, 2013) and $30,000 cash payable no later than October 17, 2013 (which was satisfied through the delivery of an additional 500,000 shares of DoMark common stock to Bioharmonics on August 15, 2013). The agreement also provides for a royalty obligation payable quarterly to Bioharmonics equal to 10% of the wholesale price for each unit using infrared and solar charging.

In January 2014, the Company executed a Licensing Agreement with Wazzamba SA. See Note 6.

Employment Agreements

On May 25, 2012, the Company entered into an employment agreement with its President, R. Brentwood Strasler, for an indefinite period or until terminated. Mr.

Strasler is entitled to an annual salary of $150,000 USD and 100,000 stock purchase warrants exercisable to purchase shares of common stock of the Company at $1.00 per share. The warrants are exercisable for a three year period and can be vested quarterly on a pro rata basis over twelve months from the date of issue. Additionally, Mr. Strasler is to be enrolled in a long term Executive Option Plan and is entitled to term life insurance in the face amount of $2,500,000, payable to the beneficiary designated by Mr. Strasler.

On June 15, 2012, the Company entered into an employment agreement with its Chief Executive Officer Andrew Ritchie, for an indefinite period or until terminated. Mr. Ritchie is entitled to an annual salary of $240,000 USD and 150,000 stock purchase warrants exercisable to purchase shares of common stock of the Company at $1.00 per share. The warrants are exercisable for a three year period and can be vested quarterly on a pro rata basis over twelve months from the date of issue. Additionally, Mr. Ritchie is to be enrolled in a long term Executive Option Plan and is entitled to term life insurance in the face amount of $2,500,000, payable to the beneficiary designated by Mr. Richie.

Lease Agreement

On August 1, 2013, the Company entered into an office lease in Toronto, Ontario, Canada for a five year period. At February 28, 2015, the future lease commitments on this lease for the years ended May 31, are as follows, and are in U.S. dollars:

2015	$	11,264
2016		47,616
2017		47,616
2018		47,616
Thereafter		7,936
Total	$	162,047

XML

Consolidated Statements Of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Feb. 28, 2015	Feb. 28, 2014	Feb. 28, 2015	Feb. 28, 2014
Consolidated Statements Of Operations
Sales
Cost of sales
Gross profit
Operating expenses:
General and administrative	27,563	438,528	269,369	759,904
Stock-based compensation - consultants	24,003	0	79,623	453,825
Stock-based compensation - Salaries and wages	0	0	0	257,476
Depreciation and amortization expense	55,360	1,360	162,080	2,080
Total operating expenses	106,926	439,888	511,072	1,473,285
Loss from operations	(106,926)	(439,888)	(511,072)	(1,473,285)
Other income (expense):
Revaluation of derivative liability for convertible notes	101,879	(342,625)	(565,302)	(504,369)
Currency Translation Loss	0	(18,569)	0	(18,569)
Interest expense	(441,262)	(262,972)	(785,492)	(350,975)
Total other income (expense)	(339,383)	(624,166)	(1,350,794)	(873,913)
Net loss	(446,309)	(1,064,054)	(1,861,866)	(2,347,198)
Statement of Comprehensive Income: Net Loss	(446,309)	(1,064,054)	(1,861,866)	(2,347,198)
Other Comprehensive Loss
Foreign Currency Adjustment	(14,213)	0	(37,902)	0
Total Other Comprehensive Loss	(14,213)	0	(37,902)	0
Total Comprehensive loss	$ (460,522)	$ (1,064,054)	$ (1,899,768)	$ (2,347,198)
Net loss per common share, basic and diluted	$ 0.00	$ (0.01)	$ 0.00	$ (0.02)
Weighted average common shares outstanding	7,743,112,656	138,202,346	6,582,724,800	96,680,371

XML

Investments

9 Months Ended

Feb. 28, 2015

Notes to Financial Statements

Note 5 - Investments

Investments consist of:

	February 28, 2015		May 31, 2014
Imagic Ltd. 40% equity interest	$	1,094,166	$	1,094,166
Barefoot Science Products & Services Inc. 15% equity interest		50,000		50,000
Total	$	1,144,166	$	1,144,166

The cost of the 40% equity interest in Imagic Ltd. at November 30, 2014 consists of:

July 22, 2013 issuance of 7,500,000 shares of DoMark common stock to Imagic Ltd. $	697,500
December 3, 2013 issuance of 8,000,000 shares of DoMark common stock to Meadow Grove Ltd. in exchange for 9% equity interest in Imagic Ltd.		96,005
Cash payments to or for the benefit of Imagic Ltd.		150,661
Payments from Foremark Holdings to Imagic Ltd. in exchange for DoMark notes payable to Foremark Holdings		150,000
Total $		1,094,166

Imagic is a privately owned company registered in Gibraltar which owns proprietary product designs for its Digilink and Game Control products. Imagic shares are not quoted or traded on any securities exchange or in any recognized overthe counter market. Imagic is accounted for on the equity method of accounting. The Company consolidates entities that we control. The Company accounts for investments in joint ventures using the equity method of accounting when we exercise significant influence over the venture. If the Company does not exercise significant influence, we account for the investment using the cost method of accounting. Imagic did not have any revenues or expenses for the period ended February 28, 2015.

XML

Convertible Notes Payable (Tables)

9 Months Ended

Feb. 28, 2015

Convertible Notes Payable Tables

Convertible notes payable

Date of		Interest			Maturity	Principal			Unamortized		Net
Note	Noteholder	Rate			Date	Amount			Discount		Note
12/19/13	JMJ Financial Inc		10	%	12/19/14	$	24,842	(i)	$	0	$	24,842
3/7/14	JSJ Investments, Inc.		12	%	10/7/14		12,130	(g)		0		12,130
3/28/14	Redwood Fund III		10	%	9/28/14		35,122	(f)		0		35,122
3/18/14	Redwood Managament, LLC.		10	%	9/28/14		50,000	(g)		0		50,000
4/14/14	WHC Capital, Inc		12	%	10/14/14		38,200	(i)		0		38,200
4/11/14	Tonaquint, Inc		12	%	10/11/14		40,559	(g)		0		40,559
4/24/14	JSJ Investments, Inc.		12	%	10/24/14		50,000	(g)		0		50,000
5/12/14	Iconic Holdings, LLC		10	%	11/12/14		46,645	(g)		0		46,645
5/16/14	KBM Worldwide, Inc		8	%	11/14/14		9,410	(l)		0		9,410
6/3/14	Adar Bays, Inc		8	%	12/12/14		48,654	(g)		0		48,654
6/23/14	JMJ Financial Inc		10	%	12/23/14		50,000	(i)		0		50,000
7/3/14	LG Capital, Inc		8	%	1/3/15		36,750	(a)		0		36,750
7/22/14	Redwood Fund III		10	%	1/22/15		100,082	(g)		0		100,082
8/14/14	KBM Worldwide, Inc		8	%	2/14/15		27,500	(l)		0		27,500
10/8/14	LG Capital, Inc		8	%	4/8/15		3,000	(a)		52		2,948
12/2/14	Tonaquint, Inc		12	%	6/2/15		10,000	(g)		9,900		100
12/5/14	LG Capital, Inc.		8	%	6/5/15		9,500	(a)		9402		98
1/7/15	LG Capital Inc		8	%	7/7/15		22,500	(a)		22,464		36
	Totals					$	614,894		$	41,818	$	573,076

XML

Subsequent Event

9 Months Ended

Feb. 28, 2015

Notes to Financial Statements

Note 13 - Subsequent Event

In January 2015, the Company entered into a joint venture agreement with Mobil Lads, Corp, to acquire 60% of Simbadeals North American licensing rights, for $700,000 value of Mobile Lads Corp common stock and $225,000 in cash. The cash will be used by Domark to pay off the existing licensing responsibilities to Wazzamba ( the program developer of Simbadeals). Mobil Lads Corp will manage the future of Simbadeals and will be fully responsible for all future funding requirements of the operation. Domark will retain a 25% interest in the Joint Venture. As of February 28, 2015 the Joint Venture payment to Domark International, Inc. from Mobil Lads, Inc. has not been made.

XML

Commitments And Contingencies (Details) (USD $)	Feb. 28, 2015
Commitments And Contingencies Details
2015	$ 11,264
2016	47,616
2017	47,616
2018	47,616
Thereafter	7,936
Total	$ 162,047

XML

Commitments and Contingencies (Tables)

9 Months Ended

Feb. 28, 2015

Commitments And Contingencies Tables

Future Lease Commitments

2015	$	11,264
2016		47,616
2017		47,616
2018		47,616
Thereafter		7,936
Total	$	162,047

XML

Fair Value Measurements and Derivative Liabiliity (Tables)

9 Months Ended

Feb. 28, 2015

Fair Value Measurements And Derivative Liabiliity Tables

Recurring Fair Value Measurements

Recurring Fair Value Measurements	Level 1		Level 2		Level 3		Total
LIABILITIES:
Derivative liability February 28, 2015		-		-		2,314,280		2,314,280
Derivative liability May 31, 2014		-		-		1,748,982		1,748,982

XML

Convertible Notes Payable (Details) (USD $)	9 Months Ended
	Feb. 28, 2015		May 31, 2014
Principal Amount	$ 614,894
Unamortized Debt Discount	41,818		674,886
Net Carrying Amount	573,076		67,414
JMJ Financial Inc. [Member]
Date of Note	Dec. 19, 2013
Interest Rate	10.00%
Maturity date	2014-12-19
Principal Amount	24,842	[1]
Unamortized Debt Discount	0
Net Carrying Amount	24,842
JSJ Investments, Inc [Member]
Date of Note	Mar. 07, 2014
Interest Rate	12.00%
Maturity date	2014-10-07
Principal Amount	12,130	[2]
Unamortized Debt Discount	0
Net Carrying Amount	12,130
Redwood Fund, III [Member]
Date of Note	Mar. 28, 2014
Interest Rate	10.00%
Maturity date	2014-09-28
Principal Amount	35,122	[3]
Unamortized Debt Discount	0
Net Carrying Amount	35,122
Redwood Management, LLC [Member]
Date of Note	Mar. 18, 2014
Interest Rate	10.00%
Maturity date	2014-09-28
Principal Amount	50,000	[2]
Unamortized Debt Discount	0
Net Carrying Amount	50,000
WHC Capital, Inc [Member]
Date of Note	Apr. 14, 2014
Interest Rate	12.00%
Maturity date	2014-10-14
Principal Amount	38,200	[1]
Unamortized Debt Discount	0
Net Carrying Amount	38,200
Tonaquint Inc [Member]
Date of Note	Apr. 11, 2014
Interest Rate	12.00%
Maturity date	2014-10-11
Principal Amount	40,559	[2]
Unamortized Debt Discount	0
Net Carrying Amount	40,559
JSJ Investments, Inc One [Member]
Date of Note	Apr. 24, 2014
Interest Rate	12.00%
Maturity date	2014-10-24
Principal Amount	50,000	[2]
Unamortized Debt Discount	0
Net Carrying Amount	50,000
Iconic Holdings, LLC [Member]
Date of Note	May 12, 2014
Interest Rate	10.00%
Maturity date	2014-11-12
Principal Amount	46,645	[2]
Unamortized Debt Discount	0
Net Carrying Amount	46,645
KBM Worldwide, Inc [Member]
Date of Note	May 16, 2014
Interest Rate	8.00%
Maturity date	2014-11-14
Principal Amount	9,410	[1]
Unamortized Debt Discount	0
Net Carrying Amount	9,410
Adar Bays, Inc [Member]
Date of Note	Jun. 03, 2014
Interest Rate	8.00%
Maturity date	2014-12-12
Principal Amount	48,654	[2]
Unamortized Debt Discount	0
Net Carrying Amount	48,654
JMJ Financial, Inc One [Member]
Date of Note	Jun. 23, 2014
Interest Rate	10.00%
Maturity date	2014-12-23
Principal Amount	50,000	[1]
Unamortized Debt Discount	0
Net Carrying Amount	50,000
LG Capital, Inc [Member]
Date of Note	Jul. 03, 2014
Interest Rate	8.00%
Maturity date	2015-01-03
Principal Amount	36,750	[4]
Unamortized Debt Discount	0
Net Carrying Amount	36,750
Redwood Fund, III One [Member]
Date of Note	Jul. 22, 2014
Interest Rate	10.00%
Maturity date	2015-01-22
Principal Amount	100,082	[2]
Unamortized Debt Discount	0
Net Carrying Amount	100,082
KBM Worldwide, Inc One [Member]
Date of Note	Aug. 14, 2014
Interest Rate	8.00%
Maturity date	2015-02-14
Principal Amount	27,500	[5]
Unamortized Debt Discount	0
Net Carrying Amount	27,500
LG Capital, Inc One [Member]
Date of Note	Oct. 08, 2014
Interest Rate	8.00%
Maturity date	2015-04-08
Principal Amount	3,000	[4]
Unamortized Debt Discount	52
Net Carrying Amount	2,948
Tonaquint, Inc One [Member]
Date of Note	Dec. 02, 2014
Interest Rate	12.00%
Maturity date	2015-06-02
Principal Amount	10,000	[5]
Unamortized Debt Discount	9,900
Net Carrying Amount	100
LG Capital, Inc. Two [Member]
Date of Note	Dec. 05, 2014
Interest Rate	8.00%
Maturity date	2015-06-05
Principal Amount	9,500	[4]
Unamortized Debt Discount	9,402
Net Carrying Amount	98
LG Capital, Inc. Three [Member]
Date of Note	Jan. 07, 2015
Interest Rate	8.00%
Maturity date	2015-07-07
Principal Amount	22,500
Unamortized Debt Discount	22,464
Net Carrying Amount	$ 36

[1] (i) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest closing price during the 25 trading days prior to the notice of conversion.

[2] (g) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 25% of the lowest trading price during the 20 trading days prior to the notice of conversion.

[3] (f) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.00929 or 50% of the average of the three lowest trading prices during the 10 trading days prior to the notice of conversion.

[4] (a) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.081 or 50% of the average of the three lowest closing prices during the 10 trading days prior to the notice of conversion.

[5] (l) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 49% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.

XML

Licensing Agreement With Wazzamba Sa (Details) (USD $)	Feb. 28, 2015	May 31, 2014	Feb. 28, 2014
Licensing Agreement With Wazzamba Sa Details
Wazzamba, S.A.	$ 300,000		$ 300,000
Bioharmonics	10,000		10,000
Subtotal	310,000		310,000
Accumulated amortization	(215,478)	(60,898)	(60,698)
Total	$ 94,522		$ 249,302

XML

Stockholders Equity (Tables)

9 Months Ended

Feb. 28, 2015

Stockholders Equity Tables

Summary of warrant activity

A summary of warrant activity for the nine months ending February 28, 2015 and for the year ended May 31, 2014 are as follows:

	Weighted Average Number of Warrants		Exercise Price
Outstanding at May 31, 2013	$	-	$	-
Granted		850,000		0.42
Exercised		-		-
Cancelled		-		-
Outstanding at May 31, 2014		850,000		0.42
Granted		-		-
Exercised		-		-
Cancelled		-		-
Outstanding at February 28, 2015	$	850,000	$	0.42

Warrants outstanding

Date Granted	Number Outstanding		Exercise price		Expiration Date
May 25, 2012		100,000	$	1.00	May 25, 2015
June 12, 2012		150,000	$	1.00	June 12, 2015
June 26, 2012		100,000	$	1.00	June 26, 2015
January 1, 2012		500,000	$	0.01	January 1, 2015
Totals		850,000

XML

Description of Business

9 Months Ended

Feb. 28, 2015

Notes to Financial Statements

Note 1 - Description of Business

DOMARK INTERNATIONAL, INC. ("DoMark" or the "Company") was incorporated under the laws of the State of Nevada on March 30, 2006. During 2008 and 2009, the Company acquired several operating businesses. On May 21, 2009, the Company entered into an acquisition agreement (the "Victory Lane Agreement") with Victory Lane Financial Elite, LLC ("Victory Lane") with respect to a real estate lifestyle business known as "Victory Lane" (the "Victory Lane Business"). Shortly thereafter, a dispute arose between the Company and the principals of Victory Lane regarding the representations of the principals of Victory Lane and the Victory Lane Business and the Victory Lane Agreement.

On March 5, 2012, the Company entered into an Asset Purchase Agreement with its then controlling shareholder, R. Thomas Kidd, for the sale of the Company’s subsidiary Armada Armada/The Golf Championships and certain assets related thereto. The Company relied upon Accounting Standards Codification (“ASC”) Topic Nos, 8602025 and 8602040 to record the sale. The fair value of the transaction was measured at the fair value of the assets less any liabilities sold.

On February 29, 2012, the Company formed a new wholly owned subsidiary, Solarwerks, Inc. in the state of Nevada, for the purposes of entering the business of marketing specialized solar consumer electronics. Solarwerks' current focus is to develop and distribute the SolaPad, a combined cover and charging system for Apple's iPad; and the SolaCase, a combined cover and charging system for all versions of Apple's iPhone. Solarwerks competes in a market that also includes 3D Systems (DDD), Dell (DELL) and Hewlett Packard (HPQ). Solarwerks, Inc. is currently in default with the Nevada Secretary of State.

On June 20, 2012, the Company formed a new whollyowned subsidiary, MuscleFoot Inc. in the state of Nevada for the purpose of distributing, marketing, and acting as sales agent for the patented foot care system of Barefoot Science. MuscleFoot Inc. is currently in default with the Nevada Secretary of State.

On July 20, 2012, the Company formed a new whollyowned subsidiary, DoMark Canada Inc. in the province of Ontario for the purpose of supporting the Company’s corporate operations based in Toronto, Ontario, Canada.

On February 28, 2013, the Company entered into a Memorandum of Understanding to purchase 44% of Zaktek Ltd. (“Zaktek”). Zaktek’s main product is the phonepad+, an Apple Inc. approved tablet device that works with smartphones, including the Apple iPhone® and Samsung Galaxy products to improve functionality including video and gaming abilities.

On April 23, 2013, the Company received notification that Zaktek was ending discussions in regards to the definitive purchase agreement with DoMark.

On June 11, 2013, the Company then purchased 100% of South Hill Ltd., an English private limited company, which owns approximately 19% of Zaktek.

XML

Basis of Presentation

9 Months Ended

Feb. 28, 2015

Notes to Financial Statements

Note 3 - Basis of Presentation

The unaudited consolidated financial statements as of February 28, 2015 and for the nine months ended February 28, 2014 have been prepared in accordance with accounting principles generally accepted in the United States for interim consolidated financial information and with instructions to Form 10Q. In the opinion of management, the unaudited consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the consolidated financial position as of February 15, 2015 and the results of operations and cash flows for the nine months ended February 28, 2015 and 2014. The financial data and other information disclosed in these notes to the interim consolidated financial statements related to these periods are unaudited. The results for the nine month period February 28, 2015 are not necessarily indicative of the results to be expected for any subsequent quarter of the entire year ending May 31, 2015. The consolidated balance sheet at February 28, 2015 has been derived from the unaudited consolidated financial statements at that date.

Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States have been omitted pursuant to the Securities and Exchange Commission’s rules and regulations. These unaudited consolidated financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended May 31, 2014 as included in our annual report on Form 10K.

XML

Licensing Agreement With Wazzamba Sa

9 Months Ended

Feb. 28, 2015

Notes to Financial Statements

Note 6 - Licensing Agreement With Wazzamba Sa

During the three months ended February 28, 2014, the Company executed a Licensing Agreement with Wazzamba SA (the “Licensor”). The agreement provides the Company an exclusive license to use certain technology (which permits thirdparty subscribers to integrate a fully equipped online shop into their websites) in Canada and the United States for an initial term ending July 31, 2015. The agreement provides for the Company to pay the Licensor “Flat Fee” compensation of $ 300,000 in 3 installments of $100,000 each (first installment payable within 5 days of the signing of the agreement, second installment payable on July 1, 2014, and third installment payable on February 1, 2015) plus “Revenue Share” compensation equal to 50% of Net Commissions generated by the Company payable monthly. In the event that the Company does not generate $500,000 in Net Commissions by January 31, 2015, the Licensor has the right to cancel the agreement with one month notice (in which case the third $100,000 installment will no longer be due). With respect to an Extended License Term after July 31, 2015, the agreement provides the Company a right of first refusal to match any offer received by the Licensor from a third party.

At February 28, 2015, the Company has a recorded intangible asset for “Licensing Agreement with Wazzamba SA” in the amount of $300,000, and included the liability under the Licenses net of accumulated amortization. Commencing March 1, 2014, the Company will amortize the $300,000 intangible asset on a straight line basis over the remaining 17 months of the Initial Term ending July 31, 2015 (approximately $17,647 per month).

On March 27, 2014, the Company paid $75,000 of the first $300,000 “Flat Fee” installment due the Licensor under the agreement. The other $225,000 due is presently past due.

Licenses, net of accumulated amortization are as follows:

	February 28,			February 28,
	2015			2014
Wazzamba S. A.	$	300,000		$	300,000
Bio harmonics		10,000			10,000
Subtotal		310,000			310,000
Accumulated amortization		(215,478	)		(60,698	)
Totals	$	94,522		$	249,302

XML

Summary of Significant Accounting Policies

9 Months Ended

Feb. 28, 2015

Notes to Financial Statements

Note 4 - Summary of Significant Accounting Policies

RECENT ACCOUNTNG PRONOUNCEMENTS

In June 2014, The Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 201410, “Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation” (“ASU 201410”). ASU 201410 removes the financial reporting distinction between development stage entities and other reporting entities and eliminates the requirements for development stage entities to (1) present inceptiontodate information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. As permitted by ASU 201410, the Company has elected early application of this standard for the accompanying consolidated financial statements for the Quarter ended February 28, 2015 and year ended May 31, 2014. The Company has reviewed other recently issued accounting pronouncements and plans to adopt those that are applicable to it. It does not expect the adoption of these pronouncements to have a material impact on its financial position, results of operations or cash flows.

PRINCIPLES OF CONSOLIDATION

The accompanying consolidated financial statements represent the consolidated financial position and results of operations of the Company and include the accounts and results of operations of the Company and its subsidiaries. The accompanying consolidated financial statements include the parent entity of DoMark International, Inc. and its wholly owned subsidiaries, Domark Canada, Inc., Solarwerks, Inc., MuscleFoot, Inc. The Company has relied upon the guidance provided by ASC Topic No. 81010153.

Foreign Currency Translation and Transaction Gains and Losses

We record foreign currency translation adjustments and transaction gains and losses in accordance with SFAS 52, Foreign Currency Translation. For our operations that have a functional currency other than the U.S. dollar, gains and losses resulting from the translation of the functional currency into U.S. dollars for financial statement presentation are not included in determining net loss but are accumulated in the cumulative foreign currency translation adjustment account as a separate component of shareholders’ deficit. The Company and its subsidiaries also have transactions in foreign currencies other than the functional currency. We record transaction gains and losses in our consolidated statements of income related to the recurring measurement and settlement of such transactions. The translation rates as of February 28, 2015 were $1.00 US equaled $1.25 Canadian.

USE OF ESTIMATES

The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates.

The primary management estimates included in these condensed consolidated financial statements are the fair value of Company stock tendered in various nonmonetary transactions and the fair value of the derivative liability for convertible notes payable.

CASH AND CASH EQUIVALENTS

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At February 28, 2015 there weren’t any cash or cash equivalents. At May 31, 2014, cash and cash equivalents consisted only of cash in the bank.

LOANS RECEIVABLE CONSULTANT

The loan receivable consultants are a short term, less than one year note, due July 15, 2015 and noninterest bearing.

NET LOSS PER COMMON SHARE

Basic net loss per common share is computed by dilutive net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially dilutive securities (such as convertible notes payable, convertible preferred stock, and warrants) outstanding during the relevant period. Dilutive securities having an antidilutive effect on diluted net loss per common share are excluded from the calculation.

For the nine months ending February 28, 2015 and 2014, diluted common shares outstanding excluded the following dilutive securities as the effect of their inclusion was antidilutive:

	Common Shares Equivalent Nine Months Ended February,
	2015		2014
Convertible notes payable		307,459,536		2,163,265
Series A convertible preferred stock		50,000,000		50,000,000
Warrants		850,000		850,000
Total common shares equivalent		358,309,536		53,013,265

INTANGIBLE ASSETS

Intangible assets are carried at cost less accumulated amortization. Amortization is recorded over the estimated useful lives of the respective assets.

IMPAIRMENT OF LONGLIVED ASSETS

In accordance with ASC Topic No. 3601040, longlived assets, such as property, plant, and equipment, and purchased intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment annually. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.

STOCKBASED COMPENSATION

The Company accounts for share based payments in accordance with ASC Topic No. 718, Compensation Stock Compensation, which requires all sharebased payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 71810309, Measurement Objective Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For stock options, the Company uses the BlackScholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as stock volatility, interest rates, and to allow for actual exercise behavior of option holders. Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued free trading shares from the Company’s authorized common stock.

ASC Topic No. 505, "CompensationStock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to nonemployees for goods or services. Under this method, stock compensation expense includes compensation expense for all stockbased compensation awards granted on or after January 1, 2006, based on the grantdate fair value estimated in accordance with the provisions of ASC 505.

RESEARCH AND DEVELOPMENT

All research and development expenditures are expensed as incurred.

REVENUE RECOGNITION

The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery and acceptance has occurred or service has been rendered, the price is fixed or determinable, and collection of the resulting receivable is reasonably assured.

XML

Summary of Significant Accounting Policies (Details)	9 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
Summary Of Significant Accounting Policies Details
Convertible notes payable	307,459,536	2,163,265
Series A convertible preferred stock	50,000,000	50,000,000
Warrants	850,000	850,000
Total common shares equivalent	358,309,536	53,013,265

XML

Licensing Agreement With Wazzamba Sa (Details Narrative) (USD $)	Feb. 28, 2015
Licensing Agreement With Wazzamba Sa Details Narrative
Intangible asset for Licensing Agreement	$ 300,000

XML

Fair Value Measurements and Derivative Liabiliity (Details) (USD $)	Feb. 28, 2015	Feb. 28, 2205
LIABILITIES
Derivative liability February 28, 2015	$ 2,314,280
Derivative liability- May 31, 2014	1,748,982
Level 1 [Member]
LIABILITIES
Derivative liability February 28, 2015
Derivative liability- May 31, 2014
Level 2 [Member]
LIABILITIES
Derivative liability February 28, 2015
Derivative liability- May 31, 2014
Level 3 [Member]
LIABILITIES
Derivative liability February 28, 2015	2,314,280
Derivative liability- May 31, 2014	$ 1,748,982

XML

Consolidated Balance Sheets (Parenthetical) (USD $)	Feb. 28, 2015	May 31, 2014
OTHER ASSETS
Patents, net of accumulated amortization	$ 11,105	$ 3,605
License, net of accumulated amortization	215,478	60,898
CURRENT LIABILITIES
Convertible notes payable net of unamortized discounts	$ 41,818	$ 674,886
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock series A, par value	$ 0.001	$ 0.001
Preferred stock series A, shares authorized	10,000,000	10,000,000
Preferred stock series A, shares issued	50,000	50,000
Preferred stock series A, shares outstanding	50,000	50,000
Convertible preferred stock series B, par value	0.0001	0.0001
Convertible preferred stock series B, shares authorized	10,000,000	10,000,000
Common Stock, par value	$ 0.001	$ 0.001
Common Stock, shares authorized	14,000,000,000	14,000,000,000
Common Stock, shares issued	8,681,112,367	801,626,781
Common Stock, shares outstanding	8,681,112,367	801,626,781
Treasury Stock, Shares	124,819,802	124,819,802

XML

Convertible Notes Payable

9 Months Ended

Feb. 28, 2015

Notes to Financial Statements

Note 9 - Convertible Notes Payable

At February 28, 2015 the convertible notes payable consisted of ;                  

Date of		Interest			Maturity	Principal			Unamortized		Net
Note	Noteholder	Rate			Date	Amount			Discount		Note
12/19/13	JMJ Financial Inc		10	%	12/19/14	$	24,842	(i)	$	0	$	24,842
3/7/14	JSJ Investments, Inc.		12	%	10/7/14		12,130	(g)		0		12,130
3/28/14	Redwood Fund III		10	%	9/28/14		35,122	(f)		0		35,122
3/18/14	Redwood Managament, LLC.		10	%	9/28/14		50,000	(g)		0		50,000
4/14/14	WHC Capital, Inc		12	%	10/14/14		38,200	(i)		0		38,200
4/11/14	Tonaquint, Inc		12	%	10/11/14		40,559	(g)		0		40,559
4/24/14	JSJ Investments, Inc.		12	%	10/24/14		50,000	(g)		0		50,000
5/12/14	Iconic Holdings, LLC		10	%	11/12/14		46,645	(g)		0		46,645
5/16/14	KBM Worldwide, Inc		8	%	11/14/14		9,410	(l)		0		9,410
6/3/14	Adar Bays, Inc		8	%	12/12/14		48,654	(g)		0		48,654
6/23/14	JMJ Financial Inc		10	%	12/23/14		50,000	(i)		0		50,000
7/3/14	LG Capital, Inc		8	%	1/3/15		36,750	(a)		0		36,750
7/22/14	Redwood Fund III		10	%	1/22/15		100,082	(g)		0		100,082
8/14/14	KBM Worldwide, Inc		8	%	2/14/15		27,500	(l)		0		27,500
10/8/14	LG Capital, Inc		8	%	4/8/15		3,000	(a)		52		2,948
12/2/14	Tonaquint, Inc		12	%	6/2/15		10,000	(g)		9,900		100
12/5/14	LG Capital, Inc.		8	%	6/5/15		9,500	(a)		9402		98
1/7/15	LG Capital Inc		8	%	7/7/15		22,500	(a)		22,464		36
	Totals					$	614,894		$	41,818	$	573,076

Legend

(a)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.081 or 50% of the average of the three lowest closing prices during the 10 trading days prior to the notice of conversion.
(b)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.085 or 60% of the lowest closing price during the 25 trading days prior to the notice of conversion.
(c)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.08 or 50% of the lowest closing price during the 10 trading days prior to the notice of conversion.
(d)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.0725 or 34% of the lowest closing price during the 20 trading days prior to the notice of conversion.
(e)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 55% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.
(f)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.00929 or 50% of the average of the three lowest trading prices during the 10 trading days prior to the notice of conversion.
(g)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 25% of the lowest trading price during the 20 trading days prior to the notice of conversion.
(h)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 58% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.
(i)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest closing price during the 25 trading days prior to the notice of conversion.
(j)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest closing price during the 20 trading days prior to the notice of conversion.
(k)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 58% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.
(l)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 49% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.

XML

Consolidated Statements Of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	$ (1,861,866)	$ (2,347,198)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	162,080	2,080
Common stock issued for compensation - consultants	79,623
Common stock issued as compensation		513,675
Non cash interest expense	785,492	336,064
Loss (gain) on derivative valuation	565,302	504,369
Changes in Operating assets and liabilities:
Prepaid expenses		3,591
Accounts payable and accrued expenses	(4,830)	48,162
Accounts payable -related party	7,644
Net cash used in operating activities	(266,555)	(939,257)
CASH FLOWS FROM INVESTING ACTIVITIES
Cash paid for investments		(171,608)
Cash paid for loan receivable from consultant		(36,203)
Net cash used in investing activities		(207,811)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from convertible notes payable	180,829	752,500
Proceeds from loans payable to consultants and stockholders	123,103	224,499
Payments made on loans payable to consultants and stockholders		(10,007)
Proceeds received from notes payable		180,000
Net cash provided by financing activities	303,932	1,146,992
Other comprehensive income ( loss ) effect of exchange rate changes on cash	(37,902)
Net decrease in cash and cash equivalents	(525)	(20)
CASH BALANCE BEGINNING OF PERIOD	460	20
CASH BALANCE (BANK OVERDRAFT) - END OF PERIOD	(65)
Cash paid for interest	20,424	9,700
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Licensing Agreement with Wazzamba SA in exchange for amounts due under Licensing agreement with Wazzamba SA		300,000
Shares issued for settlement of loans payable to consultants and stockholders	65,102	52,500
Shares issued for settlement of convertible notes payable	487,998	475,664
Shares issued for patent acquisition		35,500
Shares issued for 19% equity interest in Imagic Ltd		796,700
Convertible notes payable issued for equity interests in Imagic LTD		$ 150,000

XML

Consolidated Balance Sheets (USD $)	Feb. 28, 2015	May 31, 2014
CURRENT ASSETS
Cash and cash equivalents		$ 460
Loan receivable from consultant	36,203	36,203
Prepaid expenses	4,500	4,500
TOTAL CURRENT ASSETS	40,703	41,163
INVESTMENTS	1,144,166	1,144,166
OTHER ASSETS
Patents, net of accumulated amortization of $11,105 and $3,605, respectively	59,397	66,897
Licenses, net of accumulated amortization of $215,478 and $60,898 respectively	94,522	249,102
TOTAL OTHER ASSETS	153,919	315,999
TOTAL ASSETS	1,338,788	1,501,328
CURRENT LIABILITIES
Accounts payable to Bank	65
Note payable to bank	180,000	180,000
Accounts payable and accrued expenses	61,770	56,940
Amounts due under Licensing Agreement with Wazzamba SA	224,925	224,925
Loans payable to consultants and stockholders	181,328	188,972
Convertible notes payable (net of unamortized discounts of $41,818 and $674,886 respectively)	573,076	67,414
Derivative liability for convertible notes payable	2,314,280	1,748,982
TOTAL CURRENT LIABILITIES AND TOTAL LIABILITIES	3,535,443	2,467,233
STOCKHOLDERS' DEFICIT
Preferred stock, $0.001 par value, authorized 10,000,000 shares: Series A convertible preferred stock - issued and outstanding 50,000 shares as of February 28, 2015 and May 31, 2014	50	50
Convertible preferred stock series B, $0.0001 par value, Authorized: 10,000,000
Common stock, $0.001 par value, authorized 14,000,000,000 shares: 8,681,112,367 and 801,627,781 shares issued, and 8,681,112,367 and 801,627,781 shares outstanding, as of February 28, 2015 and May 31, 2014	8,805,928	801,627
Less: Treasury stock (124,819,802 shares) as of February 28, 2015 and May 31, 2014	(124,820)	(124,820)
Common stock payable	858,000	858,000
Additional paid-in capital	36,194,642	43,529,923
Accumulated other comprehensive income (loss)	(126,453)	(88,551)
Accumulated deficit	(47,804,002)	(45,942,134)
TOTAL STOCKHOLDERS' DEFICIT	(2,196,655)	(965,905)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 1,338,788	$ 1,501,328

XML

Investments (Details) (USD $)	Feb. 28, 2015	May 31, 2014
Investments Details
Imagic Ltd. - 40% equity interest	$ 1,094,166	$ 1,094,166
Barefoot Science Products & Services Inc. - 15% equity interest	50,000	50,000
Total	$ 1,144,166	$ 1,144,166

XML

Loans Payable to Consultants and Stockholders (Tables)

9 Months Ended

Feb. 28, 2015

Loans Payable To Consultants And Stockholders Tables

Loans payable to consultants and stockholders

	February 28,		May 31,
	2015		2014
Consultant and stockholder	$	80,796	$	90,402
President of Domark		45,850		47,500
Non-exec Chairman of Domark		-		11,875
Chairman of Barefor Science and affilliate		21,500		21,500
Consultant		16,097		16,097
Consultant		17,085		1,598
Totals	$	181,328	$	188,972

XML

Stockholders' Deficit (Details) (USD $)	9 Months Ended	12 Months Ended
	Feb. 28, 2015	May 31, 2014
Stockholders Deficit Details
Outstanding Number of Warrants, Beginning Balance	850,000
Granted		850,000
Exercised
Cancelled
Outstanding Number of Warrants, Ending Balance	850,000	850,000
Weighted Average Exercise Price, Beginning Balance	$ 0.42
Granted		$ 0.42
Exercised
Cancelled
Weighted Average Exercise Price, Ending Balance		$ 0.42

XML

Stockholders' Deficit (Details 1) (USD $)	9 Months Ended
	Feb. 28, 2015	May 31, 2014	May 31, 2013
Number Of Warrant Outstanding	850,000	850,000
Warrant [Member]
Date Granted	May 25, 2012
Number Of Warrant Outstanding	100,000
Exercise price	$ 1.00
Expiration Date	May 25, 2015
Warrant One [Member]
Date Granted	Jun. 12, 2012
Number Of Warrant Outstanding	150,000
Exercise price	$ 1.00
Expiration Date	Jun. 12, 2015
Warrant Two [Member]
Date Granted	Jun. 26, 2012
Number Of Warrant Outstanding	100,000
Exercise price	$ 1.00
Expiration Date	Jun. 26, 2015
Warrant Three [Member]
Date Granted	Jan. 01, 2012
Number Of Warrant Outstanding	500,000
Exercise price	$ 0.01
Expiration Date	Jan. 01, 2015

XML

Loans Payable to Consultants and Stockholders

9 Months Ended

Feb. 28, 2015

Notes to Financial Statements

Note 8 - Loans Payable to Consultants and Stockholders

Loans payable to consultants and stockholders consist of ;                  

	February 28,		May 31,
	2015		2014
Consultant and stockholder	$	80,796	$	90,402
President of Domark		45,850		47,500
Non-exec Chairman of Domark		-		11,875
Chairman of Barefor Science and affilliate		21,500		21,500
Consultant		16,097		16,097
Consultant		17,085		1,598
Totals	$	181,328	$	188,972

These loans are informal and do not provide for interest or a stated maturity date

XML

Investments (Details 1) (USD $)	Feb. 28, 2015	May 31, 2014
Investments Details
July 22, 2013 issuance of 7,500,000 shares of DoMark common stock to Imagic Ltd.	697,500
December 3, 2013 issuance of 8,000,000 shares of DoMark common stock to Meadow Grove Ltd. in exchange for 9% equity interest in Imagic Ltd.	96,005
Cash payments to or for the benefit of Imagic Ltd.	$ 150,661
Payments from Foremark Holdings to Imagic Ltd. in exchange for DoMark notes payable to Foremark Holdings	150,000
Total	$ 1,094,166	$ 1,094,166

XML

Fair Value Measurements and Derivative Liabiliity

9 Months Ended

Feb. 28, 2015

Notes to Financial Statements

Note 11 - Fair Value Measurements and Derivative Liabiliity

The Company evaluates all of it financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then revalued at each reporting ate, with changes in the fair value reported as charges or credits to income. For optionbased derivative financial instruments, the Companyuses the BlackScholes optionpricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is reassessed at the end of each reporting period derivative instrument liabilities are classified in the balance sheet as current or noncurrent based on whether or not netcash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

During the period ended February 28, 2015 the Company entered into several convertible note agreements. The conversion option and the outstanding common stock warrants on that date which were tainted by the convertible note were classified as derivative liabilities at their fair value on the date of issuance.

Under ASC815 the conversion options embedded in the notes payable described in Note 9 require liability classification because they do not contain an explicit limit to the number of shares that could be issued upon settlement.

As defined in FASB ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilized the market data of similar entities in its industry or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. FASB ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).

The three levels of the fair value hierarchy are as follows:

Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchangetraded derivatives, marketable securities and listed equities.

Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date.

Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

Derivative liability – the Company’s derivative liability is classified within Level 3 of the fair value hierarchy.

The Company uses the Black Scholes Option Pricing Model to value its option based derivatives predicated upon the following assumptions: dividend yield of 0%, volatility of stock price =100%, risk free interest rate varying from 8 to 12 % and an expected term equal to the remaining conversion period of the note.

The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value as of February 28, 2015.

Recurring Fair Value Measurements	Level 1		Level 2		Level 3		Total
LIABILITIES:
Derivative liability February 28, 2015		-		-		2,314,280		2,314,280
Derivative liability May 31, 2014		-		-		1,748,982		1,748,982

XML

Note Payable To Bank

9 Months Ended

Feb. 28, 2015

Notes to Financial Statements

Note 7 - Note Payable To Bank

In December 2013, the Company entered into a Loan Agreement with a bank located in Maryland. The related Promissory Note in the amount of $180,000 bears interest at a rate at 10% payable monthly, and is due in full on December 31, 2014, and is secured by a 25,000,000 shares of Domark International, Inc (Common Stock Reserve as defined in the Loan Agreement), a Guaranty of Payment from the Company’s chief financial officer and his wife, and certain real property owned by the Company’s chief financial officer and his wife. The loan has been modified and the lender has extended a six month extension for the loan repayment, with a July 1, 2015 balloon due date.

XML

Going Concern

9 Months Ended

Feb. 28, 2015

Notes to Financial Statements

Note 2 - Going Concern

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America which contemplate continuation of the Company as a going concern. Furthermore, the Company has inadequate working capital to maintain or develop its operations, and is dependent upon funds from private investors, promissory notes from lenders, and the support of certain stockholders.

These factors raise substantial doubt about the ability of the Company to continue as a going concern. These condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty. In this regard, management is planning to raise any necessary additional funds through loans and additional sales of its common stock. There isn’t any assurance that the Company will be successful in raising additional capital to meet its operating needs.

XML

Loans Payable to Consultants and Stockholders (Details) (USD $)	Feb. 28, 2015	May 31, 2014
Loans payable to consultants and stockholders	$ 181,328	$ 188,972
Consultant And Stockholder [Member]
Loans payable to consultants and stockholders	80,796	90,402
President Of DoMark [Member]
Loans payable to consultants and stockholders	45,850	47,500
Non Exec Chairman Of Domark [Member]
Loans payable to consultants and stockholders		11,875
Chairman Of Barefoot Science And Affiliate [Member]
Loans payable to consultants and stockholders	21,500	21,500
Consultant [Member]
Loans payable to consultants and stockholders	16,097	16,097
Consultant One [Member]
Loans payable to consultants and stockholders	$ 17,085	$ 1,598

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Feb. 28, 2015

Summary Of Significant Accounting Policies Policies

Recent Accountng Pronouncements

In June 2014, The Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 201410, “Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation” (“ASU 201410”). ASU 201410 removes the financial reporting distinction between development stage entities and other reporting entities and eliminates the requirements for development stage entities to (1) present inceptiontodate information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. As permitted by ASU 201410, the Company has elected early application of this standard for the accompanying consolidated financial statements for the Quarter ended February 28, 2015 and year ended May 31, 2014. The Company has reviewed other recently issued accounting pronouncements and plans to adopt those that are applicable to it. It does not expect the adoption of these pronouncements to have a material impact on its financial position, results of operations or cash flows.

Principles of Consolidation

The accompanying consolidated financial statements represent the consolidated financial position and results of operations of the Company and include the accounts and results of operations of the Company and its subsidiaries. The accompanying consolidated financial statements include the parent entity of DoMark International, Inc. and its wholly owned subsidiaries, Domark Canada, Inc., Solarwerks, Inc., MuscleFoot, Inc. The Company has relied upon the guidance provided by ASC Topic No. 81010153.

Foreign Currency Translation and Transaction Gains and Losses

We record foreign currency translation adjustments and transaction gains and losses in accordance with SFAS 52, Foreign Currency Translation. For our operations that have a functional currency other than the U.S. dollar, gains and losses resulting from the translation of the functional currency into U.S. dollars for financial statement presentation are not included in determining net loss but are accumulated in the cumulative foreign currency translation adjustment account as a separate component of shareholders’ deficit. The Company and its subsidiaries also have transactions in foreign currencies other than the functional currency. We record transaction gains and losses in our consolidated statements of income related to the recurring measurement and settlement of such transactions. The translation rates as of February 28, 2015 were $1.00 US equaled $1.25 Canadian.

Use of Estimates

The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates.

The primary management estimates included in these condensed consolidated financial statements are the fair value of Company stock tendered in various nonmonetary transactions and the fair value of the derivative liability for convertible notes payable.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At February 28, 2015 there weren’t any cash or cash equivalents. At May 31, 2014, cash and cash equivalents consisted only of cash in the bank.

Loans Receivable Consultant

The loan receivable consultants are a short term, less than one year note, due July 15, 2015 and noninterest bearing.

Net Loss Per Common Share

Basic net loss per common share is computed by dilutive net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially dilutive securities (such as convertible notes payable, convertible preferred stock, and warrants) outstanding during the relevant period. Dilutive securities having an antidilutive effect on diluted net loss per common share are excluded from the calculation.

For the nine months ending February 28, 2015 and 2014, diluted common shares outstanding excluded the following dilutive securities as the effect of their inclusion was antidilutive:

	Common Shares Equivalent Nine Months Ended February,
	2015		2014
Convertible notes payable		307,459,536		2,163,265
Series A convertible preferred stock		50,000,000		50,000,000
Warrants		850,000		850,000
Total common shares equivalent		358,309,536		53,013,265

Intangible Assets

Intangible assets are carried at cost less accumulated amortization. Amortization is recorded over the estimated useful lives of the respective assets.

Impairment of Long-Lived Assets

In accordance with ASC Topic No. 3601040, longlived assets, such as property, plant, and equipment, and purchased intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment annually. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.

Stock Based Compensation

The Company accounts for share based payments in accordance with ASC Topic No. 718, Compensation Stock Compensation, which requires all sharebased payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 71810309, Measurement Objective Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For stock options, the Company uses the BlackScholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as stock volatility, interest rates, and to allow for actual exercise behavior of option holders. Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued free trading shares from the Company’s authorized common stock.

ASC Topic No. 505, "CompensationStock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to nonemployees for goods or services. Under this method, stock compensation expense includes compensation expense for all stockbased compensation awards granted on or after January 1, 2006, based on the grantdate fair value estimated in accordance with the provisions of ASC 505.

Research and Development

All research and development expenditures are expensed as incurred.

Revenue Recognition

The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery and acceptance has occurred or service has been rendered, the price is fixed or determinable, and collection of the resulting receivable is reasonably assured.

XML

Stockholders Equity

9 Months Ended

Feb. 28, 2015

Notes to Financial Statements

Note 10 - Stockholders Equity

Series A Convertible Preferred Stock

Each share of Series A Convertible Preferred Stock has 1,000 voting rights and is convertible into 1,000 shares of common stock.

Common Stock Issuances

On December 1, 2014, the Company issued 233,356,500 shares of common stock for LG Capital, Inc. in satisfaction of $4,667 of principal amount of convertible notes payable.

On December 3, 2014, the Company issued 164,350,200 shares of common stock for Redwood Fund III, Inc.in satisfaction of $ 3,287 of principal amount of convertible notes payable.

On December 5, 2014, the Company issued 228,000,000 shares of common stock for KBM Worldwide, Inc. in satisfaction of $11,400 of principal amount of convertible notes payable.

On December 10, 2014, the Company issued 128,428,577 shares of common stock for Iconic Holdings, LLC in satisfaction of $ 3,148 of principal amount of convertible notes payable

On December 10, 2014, the Company issued 200,000,000 shares of common stock for WHC Capital, Inc. in satisfaction of $4,800 of principal amount of convertible notes payable.

On December 10, 2014, the Company issued 157,500,000 shares of common stock for Tonaquint, Inc. in satisfaction of $3,937 of principal amount of convertible notes payable.

On December 16,, 2014, the Company issued 307,937,698 shares of common stock for JSJ Investments, Inc. in satisfaction of $7,698 of principal amount of convertible notes payable.

On December 22, 2014, the Company issued 318,000,000 shares of common stock for JMJ Financial, Inc. in satisfaction of $19,080 of principal amount of convertible notes payable.

On December 30, 2014, the Company issued 153,846,000 shares of common stock for Adars Bay, Inc. in satisfaction of $3,846 of principal amount of convertible notes payable.

On December 31, 2014, the Company issued 181,200,000 shares of common stock for KBM Worldwide, Inc. in satisfaction of $9,060 of principal amount of convertible notes payable.

On December 31, 2014, the Company issued 256,044,000 shares of common stock for LG Capital, Inc.in satisfaction of $5,121 of principal amount of convertible notes payable.

On December 31, 2014, the Company issued 46,800,000 shares of common stock for KBM Worldwide, Inc. in satisfaction of $2,340 of principal amount of convertible notes payable.

On December 31, 2014, the Company issued 181,200,000 shares of common stock to KBM Worldwide, Inc. in satisfaction of $9,060 of principal amount of convertible notes payable.

On December 31, 2014, the Company issued 256,044,000 shares of common stock to LG Capital, Inc., Inc. in satisfaction of $5,121 principal amount of convertible notes payable.

On January 12, 2015, the Company issued 160,000,000 shares of common stock to Tonaquint, Inc.in satisfaction of $4,000 principal amount of convertible notes payable.

On February 17, 2015, the Company issued 280,600,000 shares of common stock to KBM Worldwide, Inc. in satisfaction of $ 14,030 principal amount of convertible notes payable.

Warrants to Purchase Common Stock

A summary of warrant activity for the nine months ending February 28, 2015 and for the year ended May 31, 2014 are as follows:

	Weighted Average Number of Warrants		Exercise Price
Outstanding at May 31, 2013	$	-	$	-
Granted		850,000		0.42
Exercised		-		-
Cancelled		-		-
Outstanding at May 31, 2014		850,000		0.42
Granted		-		-
Exercised		-		-
Cancelled		-		-
Outstanding at February 28, 2015	$	850,000	$	0.42

Warrants outstanding at February 28, 2015 consist of:

Date Granted	Number Outstanding		Exercise price		Expiration Date
May 25, 2012		100,000	$	1.00	May 25, 2015
June 12, 2012		150,000	$	1.00	June 12, 2015
June 26, 2012		100,000	$	1.00	June 26, 2015
January 1, 2012		500,000	$	0.01	January 1, 2015
Totals		850,000

XML

Licensing Agreement With Wazzamba Sa (Tables)

9 Months Ended

Feb. 28, 2015

Licensing Agreement With Wazzamba Sa Tables

Licenses, net of accumulated amortization

	February 28,			February 28,
	2015			2014
Wazzamba S. A.	$	300,000		$	300,000
Bio harmonics		10,000			10,000
Subtotal		310,000			310,000
Accumulated amortization		(215,478	)		(60,698	)
Totals	$	94,522		$	249,302

XML

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Feb. 28, 2015

Summary Of Significant Accounting Policies Tables

Net Loss Per Common Share

	Common Shares Equivalent Nine Months Ended February,
	2015		2014
Convertible notes payable		307,459,536		2,163,265
Series A convertible preferred stock		50,000,000		50,000,000
Warrants		850,000		850,000
Total common shares equivalent		358,309,536		53,013,265

XML

Document and Entity Information	9 Months Ended
	Feb. 28, 2015
Document And Entity Information
Entity Registrant Name	Domark International Inc.
Entity Central Index Key	0001365160
Document Type	10-Q
Document Period End Date	Feb. 28, 2015
Amendment Flag	false
Current Fiscal Year End Date	--05-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding	8,681,112,367
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2015

XML

Investments (Tables)

9 Months Ended

Feb. 28, 2015

Investments Tables

Investments

	February 28, 2015		May 31, 2014
Imagic Ltd. 40% equity interest	$	1,094,166	$	1,094,166
Barefoot Science Products & Services Inc. 15% equity interest		50,000		50,000
Total	$	1,144,166	$	1,144,166

Cost of equity interest

July 22, 2013 issuance of 7,500,000 shares of DoMark common stock to Imagic Ltd. $	697,500
December 3, 2013 issuance of 8,000,000 shares of DoMark common stock to Meadow Grove Ltd. in exchange for 9% equity interest in Imagic Ltd.		96,005
Cash payments to or for the benefit of Imagic Ltd.		150,661
Payments from Foremark Holdings to Imagic Ltd. in exchange for DoMark notes payable to Foremark Holdings		150,000
Total $		1,094,166